Skip to main content
. 2015 Apr 7;6(11):8676–8686. doi: 10.18632/oncotarget.3254

Figure 7. Clinical relevance of miR-129-5p, YAP, TAZ, CTGF and Cyclin A in ovarian cancer.

Figure 7

(A and B) Expression analysis (A) and correlation (B) of miR-129-5p expression and YAP, TAZ protein expression, and CTGF, Cyclin A mRNA levels in nine freshly collected human ovarian cancer tissue samples (T) The ratio of first sample (YAP/α-tubulin, TAZ/α-tubulin) was considered as 1.0. α-Tubulin were used as loading controls. Each bar represents the mean ± SD of three independent experiments.